Paul Tudor Jones Gilead Sciences, Inc. Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 310,566 shares of GILD stock, worth $22 Million. This represents 0.15% of its overall portfolio holdings.
Number of Shares
310,566
Previous 37,430
729.72%
Holding current value
$22 Million
Previous $3.03 Million
650.26%
% of portfolio
0.15%
Previous 0.02%
Shares
22 transactions
Others Institutions Holding GILD
# of Institutions
1,884Shares Held
1BCall Options Held
8.71MPut Options Held
8.02M-
Black Rock Inc. New York, NY123MShares$8.67 Billion0.21% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$8.12 Billion0.17% of portfolio
-
Capital World Investors Los Angeles, CA84.5MShares$5.98 Billion1.06% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.2MShares$4.33 Billion1.05% of portfolio
-
State Street Corp Boston, MA57.7MShares$4.08 Billion0.19% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $88.7B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...